PBT up 28.1% as Glassons Australia drives unprecedented margin expansion

Both the revenue growth rate and the implied PBT margin of 13.4% sit above Annolyse's historical baseline, where revenue growth has averaged 7.8% (range 0.1%–16.7%) and PBT margin has averaged 11.4% (range 10.0%–12.4%).

PBT growth ran 8.3 percentage points ahead of NPAT growth because the effective tax rate normalised from 24.4% in FY20 to 29.0% in FY21, so PBT is the cleaner read on operating performance.

Operating cash flow fell 13.9% to NZ$61.4m even as PBT rose 28.1%, and closing cash declined NZ$10.4m to NZ$39.2m. The Directors deferred declaring a final dividend pending clarity on the Auckland and Australian lockdowns.

The Australian segment grew revenue 38.2% to NZ$133.6m and segment profit 75.3% to NZ$23.5m, lifting its share of group revenue to 38.1% from 33.6%. Glassons New Zealand revenue grew 16.9% but its segment result was flat (NZ$16.1m vs NZ$16.3m), and Hallensteins delivered only modest profit growth on 9.9% revenue gain. The group's earnings step-up is concentrated in a single brand-country combination, which means the durability question sits squarely with Australian Glassons trading.

Tax normalisation, not weaker operations, explains the NPAT/PBT gap. The 8.3pp gap between PBT growth (28.1%) and NPAT growth (19.8%) reflects the effective tax rate moving from an unusually low 24.4% back to 29.0% — within the historical range of 27.0%–33.8%. Readers anchoring on the headline 20.0% NPAT lift are understating the underlying operating improvement.

Cash conversion deteriorated against a stronger P&L. Operating cash flow fell NZ$9.9m while PBT rose NZ$10.2m, driven by an inventory build (+NZ$3.2m) and other working-capital absorption. Pre-lease free cash flow of NZ$53.5m remains within Annolyse's historical range of NZ$44.2m–NZ$72.8m but sits NZ$6.4m below the four-period mean of NZ$59.9m, meaning earnings quality on a cash basis stepped back even as accounting margins expanded.

The release confirms the Directors deferred declaring a final dividend specifically because of the Auckland and Australian lockdowns that began after the balance date, which means the FY21 result reflects a trading period that has already changed shape post-year-end.

Half-year context shows HY21 delivered 51.9% of full-year revenue and 59.5% of full-year NPAT, so the second half was modestly softer on profit despite Australian momentum. With FY22 trading already disrupted by lockdowns at announcement, the FY21 numbers do not support a clean run-rate read into the new year.

Tax normalisation works against, not for, the headline NPAT number.

The cash story is weaker. Operating cash flow fell 13.9% as inventory and working capital absorbed cash, and capex fell 33.3% to NZ$7.9m (2.3% of revenue), so the FCF/NPAT conversion of 160.7% is flattered by lower investment rather than stronger cash generation. Net cash declined NZ$10.4m despite record earnings, which means dividend capacity in FY22 depends partly on whether the inventory build unwinds without further working-capital pressure.

This briefing cannot assess current trading momentum under the post-balance-date Auckland and Australian lockdowns referenced in the release.